Object. Hemangioblastomas of the brainstem constitute 5 to 10% of central nervous system (CNS) tumors in patients with von Hippel—Lindau (VHL) disease. At present, optimal management of brainstem hemangioblastomas associated with VHL disease is incompletely defined. In an attempt to clarify some of the uncertainty about the operative treatment of these lesions and its outcome, the authors reviewed all cases of VHL disease in which resection of brainstem hemangioblastomas was performed at the National Institutes of Health during a 10-year period.
Methods. Twelve consecutive patients with VHL disease (six male and six female patients [mean age 31.7 ± 9 years; range 15–46 years]) who underwent 13 operations to remove 17 brainstem hemangioblastomas were included in this study (mean follow-up period, 88.4 ± 37.4 months; range 37–144 months). Serial examinations, hospital charts, magnetic resonance images, and operative records were reviewed. To evaluate clinical course, clinical grades were assigned to each patient before and after surgery.
Preoperative neurological function was the best predictor of long-term outcome. In addition, patients who underwent CNS surgeries for hemangioblastomas were more likely to improve or to remain neurologically stable. Tumor or cyst size, the presence of a cyst, or the location of the tumor (intramedullary, extramedullary, or mixed; posterior medullary, obex, or lateral) did not affect outcome. No patient was neurologically worse after brainstem surgery. At long-term follow-up review (mean 88.4 months), only one patient had declined neurologically and this was due to the cumulative neurological effects caused by eight additional hemangioblastomas of the spinal cord and their surgical treatment.
Conclusions. Brainstem hemangioblastomas in patients with VHL disease can be removed safely; they generally should be resected when they become symptomatic or when the tumor has reached a size such that further growth will increase the risks associated with surgery, or in the presence of an enlarging cyst. Magnetic resonance imaging is usually sufficient for preoperative evaluation and presurgical embolization is unnecessary. The goal of surgery is complete resection of the lesion before the patient experiences a disabling neurological deficit.
Ahyai A, , Woerner U, & Markakis E: Surgical treatment of intramedullary tumors (spinal cord and medulla oblongata). Analysis of 16 cases. Neurosurg Rev 13:45–52, 1990 Ahyai A, Woerner U, Markakis E: Surgical treatment of intramedullary tumors (spinal cord and medulla oblongata). Analysis of 16 cases. Neurosurg Rev 13:45–52, 1990
Baumgartner JE, & Wilson CB: Removal of posterior fossa and spinal hemangioblastomas, in CB Wilson (ed): Neurosurgical Procedures: Personal Approaches to Classic Operations. Baltimore: Williams & Wilkins, 1992, pp 188–199 Baumgartner JE, Wilson CB: Removal of posterior fossa and spinal hemangioblastomas, in CB Wilson (ed): Neurosurgical Procedures: Personal Approaches to Classic Operations. Baltimore: Williams & Wilkins, 1992, pp 188–199
Brauch H, , Kishida T, & Glavac D, et al: Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum Genet 95:551–556, 1995 Brauch H, Kishida T, Glavac D, et al: Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum Genet 95:551–556, 1995
Chang SD, , Meisel JA, & Hancock SL, et al: Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:28–35, 1998 Chang SD, Meisel JA, Hancock SL, et al: Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:28–35, 1998
Chen F, , Kishida T, & Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66–75, 1995 Chen F, Kishida T, Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66–75, 1995
Chen F, , Slife L, & Kishida T, et al: Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. J Med Genet 33:716–717, 1996 Chen F, Slife L, Kishida T, et al: Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. J Med Genet 33:716–717, 1996
Chou SN, , Erickson DL, & Oritiz-Suarez HJ: Surgical treatment of vascular lesions in the brain stem. J Neurosurg 42:23–31, 1975 Chou SN, Erickson DL, Oritiz-Suarez HJ: Surgical treatment of vascular lesions in the brain stem. J Neurosurg 42:23–31, 1975
Collins ET: Intra-ocular growths. Two cases, brother and sister, with peculiar vascular new growth, probably primarily retinal, affecting both eyes. Trans Ophthalmol Soc UK 14:141–149, 1894 (Reference unverified) Collins ET: Intra-ocular growths. Two cases, brother and sister, with peculiar vascular new growth, probably primarily retinal, affecting both eyes. Trans Ophthalmol Soc UK 14:141–149, 1894 (Reference unverified)
Constans JP, , Meder F, & Maiuri F, et al: Posterior fossa hemangioblastomas. Surg Neurol 25:269–275, 1986 Constans JP, Meder F, Maiuri F, et al: Posterior fossa hemangioblastomas. Surg Neurol 25:269–275, 1986
Conway JE, , Chou D, & Clatterbuck RE, et al: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55–63, 2001 Conway JE, Chou D, Clatterbuck RE, et al: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55–63, 2001
Crossey PA, , Foster K, & Richards FM, et al: Molecular genetic investigations of the mechanism of tumorigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 93:53–58, 1994 Crossey PA, Foster K, Richards FM, et al: Molecular genetic investigations of the mechanism of tumorigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 93:53–58, 1994
Cushing H, & Bailey P: Hemangiomas of cerebellum and retina (Lindau's disease). With the report of a case. Arch Ophthalmol 57:447–463, 1928 Cushing H, Bailey P: Hemangiomas of cerebellum and retina (Lindau's disease). With the report of a case. Arch Ophthalmol 57:447–463, 1928
Djindjian M: Successful removal of a brainstem hemangioblastoma. Surg Neurol 25:97–100, 1986 Djindjian M: Successful removal of a brainstem hemangioblastoma. Surg Neurol 25:97–100, 1986
Duan DR, , Humphrey JS, & Chen DYT, et al: Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92:6459–6463, 1995 Duan DR, Humphrey JS, Chen DYT, et al: Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92:6459–6463, 1995
Duan DR, , Pause A, & Burgess WH, et al: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402–1406, 1995 Duan DR, Pause A, Burgess WH, et al: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402–1406, 1995
Filling-Katz MR, , Choyke PL, & Oldfield E, et al: Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:41–46, 1991 Filling-Katz MR, Choyke PL, Oldfield E, et al: Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:41–46, 1991
Glenn GM, , Linehan WM, & Hosoe S, et al: Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA 267:1226–1231, 1992 Glenn GM, Linehan WM, Hosoe S, et al: Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA 267:1226–1231, 1992
Hosoe S, , Brauch H, & Latif F, et al: Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634–640, 1990 Hosoe S, Brauch H, Latif F, et al: Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634–640, 1990
Iliopoulos O, , Kibel A, & Gray S, et al: Tumor suppression by the human von Hippel-Lindau gene product. Nat Med 1:822–826, 1995 Iliopoulos O, Kibel A, Gray S, et al: Tumor suppression by the human von Hippel-Lindau gene product. Nat Med 1:822–826, 1995
Jackson H: A series of cases illustrative of cerebral pathology. I—Cerebral tumors. Med Times Hosp Gaz (London) 2:541–568, 1872 (Reference unverified) Jackson H: A series of cases illustrative of cerebral pathology. I—Cerebral tumors. Med Times Hosp Gaz (London) 2:541–568, 1872 (Reference unverified)
Kanno H, , Kondo K, & Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845–4847, 1994 Kanno H, Kondo K, Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845–4847, 1994
Kishida T, , Stackhouse TM, & Chen F, et al: Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544–4548, 1995 Kishida T, Stackhouse TM, Chen F, et al: Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544–4548, 1995
Kohno K, , Matsui S, & Nishizaki A, et al: Successful total removal of intramedullary hemangioblastoma from the medulla oblongata. Surg Neurol 39:25–30, 1993 Kohno K, Matsui S, Nishizaki A, et al: Successful total removal of intramedullary hemangioblastoma from the medulla oblongata. Surg Neurol 39:25–30, 1993
Knudson AG Jr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437–1443, 1985 Knudson AG Jr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437–1443, 1985
Latif F, , Tory K, & Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320, 1993 Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320, 1993
Lindau A: Studien über Kleinhirncysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand Supp 1:1–128, 1926 Lindau A: Studien über Kleinhirncysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol Microbiol Scand Supp 1:1–128, 1926
Lindau A: Zur Frage der Angiomatosis retinae und ihrer Hirnkomplikationen. Acta Ophthalmol 4:193–226, 1927 Lindau A: Zur Frage der Angiomatosis retinae und ihrer Hirnkomplikationen. Acta Ophthalmol 4:193–226, 1927
Lonser RR, , Weil RJ, & Wanebo, JE, et al: Surgical management of spinal cord hemangioblastomas in patients with von Hippel—Lindau disease. J Neurosurg 98:106–116, 2003 Lonser RR, Weil RJ, Wanebo, JE, et al: Surgical management of spinal cord hemangioblastomas in patients with von Hippel—Lindau disease. J Neurosurg 98:106–116, 2003
Lundin P, & Pedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:519–528, 1992 Lundin P, Pedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:519–528, 1992
Maher ER, , Webster AR, & Moore AT: Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:79–84, 1995 Maher ER, Webster AR, Moore AT: Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:79–84, 1995
Maher ER, , Yates JRW, & Harries R, et al: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163, 1990 Maher ER, Yates JRW, Harries R, et al: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163, 1990
Manski TJ, , Heffner DK, & Glenn GM, et al: Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461–1466, 1997 Manski TJ, Heffner DK, Glenn GM, et al: Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461–1466, 1997
McCormick PC, , Torres R, & Post KD, et al: Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523–532, 1990 McCormick PC, Torres R, Post KD, et al: Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523–532, 1990
Melmon KL, & Rosen SW: Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36:595–617, 1964 Melmon KL, Rosen SW: Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36:595–617, 1964
Neumann HP, , Eggert HR, & Scheremet R, et al: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898–901, 1992 Neumann HP, Eggert HR, Scheremet R, et al: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898–901, 1992
Neumann HP, , Eggert HR, & Weigel K, et al: Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:24–30, 1989 Neumann HP, Eggert HR, Weigel K, et al: Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:24–30, 1989
Niemela M, , Lim YJ, & Soderman M, et al: Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591–596, 1996 Niemela M, Lim YJ, Soderman M, et al: Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591–596, 1996
Nishimoto A, & Kawakami Y: Surgical removal of hemangioblastoma in the fourth ventricle. Surg Neurol 13:423–427, 1980 Nishimoto A, Kawakami Y: Surgical removal of hemangioblastoma in the fourth ventricle. Surg Neurol 13:423–427, 1980
Rawe SE, , Van Gilder JC, & Rothman SLG: Radiographic diagnostic evaluation and surgical treatment of multiple cerebellar, brain stem, and spinal cord hemangioblastomas. Surg Neurol 9:337–341, 1978 Rawe SE, Van Gilder JC, Rothman SLG: Radiographic diagnostic evaluation and surgical treatment of multiple cerebellar, brain stem, and spinal cord hemangioblastomas. Surg Neurol 9:337–341, 1978
Rengachary SS, & Blount JP: Hemangioblastomas, in Wilkins RH, & Rengachary SS (eds): Neurosurgery, ed 2. New York: McGraw-Hill, 1996, Vol 1, pp 1205–1219 Rengachary SS, Blount JP: Hemangioblastomas, in Wilkins RH, Rengachary SS (eds): Neurosurgery, ed 2. New York: McGraw-Hill, 1996, Vol 1, pp 1205–1219
Richard S, , David P, & Marsot-Dupuch K, et al: Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 23:1–24, 2000 Richard S, David P, Marsot-Dupuch K, et al: Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 23:1–24, 2000
Sanford RA, & Smith RA: Hemangioblastoma of the cervicomedullary junction. Report of three cases. J Neurosurg 64:317–321, 1986 Sanford RA, Smith RA: Hemangioblastoma of the cervicomedullary junction. Report of three cases. J Neurosurg 64:317–321, 1986
Seizinger BR, , Rouleau GA, & Ozelius LJ, et al: von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269, 1988 Seizinger BR, Rouleau GA, Ozelius LJ, et al: von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269, 1988
Silverberg GD, , Reitz BA, & Ream AK: Hypothermia and cardiac arrest in the treatment of giant aneurysms of the cerebral circulation and hemangioblastoma of the medulla. J Neurosurg 55:337–346, 1981 Silverberg GD, Reitz BA, Ream AK: Hypothermia and cardiac arrest in the treatment of giant aneurysms of the cerebral circulation and hemangioblastoma of the medulla. J Neurosurg 55:337–346, 1981
Spetzger U, , Bertalanffy H, & Huffmann B, et al: Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev 19:147–151, 1996 Spetzger U, Bertalanffy H, Huffmann B, et al: Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev 19:147–151, 1996
Standard SC, , Ahuja A, & Livingston K, et al: Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas. Surg Neurol 41:405–410, 1994 Standard SC, Ahuja A, Livingston K, et al: Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas. Surg Neurol 41:405–410, 1994
Tognetti F, , Galassi E, & Servadei F, et al: Haemangioblastomas of the brain stem. Neurochirurgia 29:230–234, 1986 Tognetti F, Galassi E, Servadei F, et al: Haemangioblastomas of the brain stem. Neurochirurgia 29:230–234, 1986
Tory K, , Brauch H, & Linehan M, et al: Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 81:1097–1101, 1989 Tory K, Brauch H, Linehan M, et al: Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 81:1097–1101, 1989
von Hippel E: Vorstellung eine patienten mit einer sehr ungewohnlieben netzhant. Ber Ophthalmol Ges 24:269, 1895 (Reference unverified) von Hippel E: Vorstellung eine patienten mit einer sehr ungewohnlieben netzhant. Ber Ophthalmol Ges 24:269, 1895 (Reference unverified)
Vortmeyer AO, , Gnarra JR, & Emmert-Buck MR, et al: von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540–543, 1997 Vortmeyer AO, Gnarra JR, Emmert-Buck MR, et al: von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540–543, 1997
Wanebo JE, , Lonser RR, & Glen GN, et al: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. J Neurosurg 98:82–94, 2003.Wanebo JE, Lonser RR, Glen GN, et al: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. J Neurosurg 98:82–94, 2003.
Yang H, & Kaelin WG Jr: Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing. Cell Growth Differ 12:447–455, 2001 Yang H, Kaelin WG Jr: Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing. Cell Growth Differ 12:447–455, 2001
Yasargil MG: Microneurosurgery: In 4 Volumes. New York: Thieme Stratton, 1996, Vol IVB, pp 386–389 Yasargil MG: Microneurosurgery: In 4 Volumes. New York: Thieme Stratton, 1996, Vol IVB, pp 386–389
Yasargil MG, , Antic J, & Laciga R, et al: The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surg Neurol 3:141–8, 1976 Yasargil MG, Antic J, Laciga R, et al: The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surg Neurol 3:141–8, 1976
Zbar B, , Kishida T, & Chen F, et al: Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348–357, 1996 Zbar B, Kishida T, Chen F, et al: Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348–357, 1996
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 861 | 241 | 26 |
Full Text Views | 295 | 31 | 5 |
PDF Downloads | 191 | 27 | 4 |
EPUB Downloads | 0 | 0 | 0 |